Clinical Trials
All Clinical Trials - Page 60 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01075282Phase 3Completed
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
Dulaglutide
- NCT01064687Phase 3Completed
A Study in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT01093729Phase 1Completed
A Study of HM11260C in Healthy Male Subject
Exenatide
- NCT00747968Phase 2/Phase 3Completed
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
Exenatide
- NCT01063504Phase 2Completed
Teriparatide for Improved Knee Prosthesis Fixation
Teriparatide
- NCT01070758Phase 4Completed
Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy
Octreotide
- NCT02310074Phase 4Unknown
Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism
Gonadorelin
- NCT01029886Phase 3Completed
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT01061775Phase 1/Phase 2Completed
Effects of Exenatide on Hypothalamic Obesity
Exenatide
- NCT01056549N/ACompleted
Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
Exenatide
- NCT01212224N/ACompleted
A Study of Minirin Melt in Patients With Nocturia
Desmopressin
- NCT00994929Phase 2Completed
Efficacy and Safety of IL-11 in DDAVP Unresponsive
Desmopressin
- NCT01078753Phase 3Completed
Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis
Desmopressin
- NCT01088529Phase 2Completed
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
Gonadorelin
- NCT01036841Phase 4Completed
Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation
Desmopressin
- NCT01031966Phase 2Completed
A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
Thymosin-Alpha-1
- NCT01778452N/ACompleted
Endometrial Genomic Profile in Endometrial Priming
Gonadorelin
- NCT00924469Phase 2Completed
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer
Gonadorelin
- NCT00943501Phase 1Completed
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide
- NCT01254123Phase 3Unknown
Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
Exenatide
- NCT01011556Phase 2Completed
A Study for the Transdermal Application of Teriparatide
Teriparatide
- NCT01028924Phase 1Completed
Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers
Teduglutide
- NCT01003873N/ACompleted
Gastric Bypass and Peripheral Activity of the Endocannabinoid System
Ghrp-6
- NCT00949962Phase 3Terminated
Post-operative or Early Salvage XRT and ADT for High Risk PCa
Gonadorelin
- NCT01339299Phase 4Completed
Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)
Gonadorelin
- NCT00993720Phase 2/Phase 3Completed
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
Liraglutide
- NCT00993304Phase 1Completed
A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
Liraglutide
- NCT01001104Phase 2Completed
A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
Dulaglutide
- NCT01003184Phase 3Completed
Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
Exenatide
- NCT00975286Phase 3Completed
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
Lixisenatide
- NCT02305069N/ACompleted
Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle
Octreotide
- NCT01076803Phase 2Completed
Efficacy and Safety of Lanreotide 120 Milligram (mg) as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients
Lanreotide
- NCT01028768Phase 1Completed
Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function
Teduglutide
- NCT01534117N/ACompleted
Platelet Function Analysis in Head Trauma: ASA/Plavix
Desmopressin
- NCT00930644Phase 3Completed
Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
Teduglutide
- NCT00978393Phase 1Completed
A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
Liraglutide
- NCT00979745Phase 3Completed
Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Afamelanotide
- NCT03634137Phase 1Completed
Implant Pharmacokinetic and Pharmacodynamic Study
Afamelanotide
- NCT00983021Phase 1Completed
Safety and Tolerability of NN9068 in Healthy Male Volunteers
Liraglutide
- NCT01046721N/ACompleted
Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
Exenatide
- NCT00960661Phase 3Completed
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
Exenatide
- NCT01580514Phase 4Completed
Myocardial Protection of Exenatide in AMI
Exenatide
- NCT00964262Phase 1Completed
A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
Exenatide
- NCT00943917Phase 2Completed
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT01269047Phase 4Completed
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
Exenatide
- NCT01165944Phase 1/Phase 2Withdrawn
Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus
Pramlintide
- NCT00790699N/ATerminated
Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port
Pramlintide
- NCT00976937Phase 3Completed
24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years
Lixisenatide
- NCT00981682Phase 3Completed
Long Term Safety Assessment of SER120 in Patients With Nocturia
Desmopressin
- NCT00935558Phase 2Withdrawn
Dendritic Cell Based Therapy for Breast Cancer Patients
Thymosin-Alpha-1